BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19

• Press Releases

  InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 12, 2026

  June 14, 2026

   · 

  6 min read
• Press Releases

  Cartesian Therapeutics Announces New Employment Inducement Grant - June 12, 2026

  June 14, 2026

   · 

  1 min read
• Press Releases

  4DMT Announces New Employment Inducement Grants - June 12, 2026

  June 14, 2026

   · 

  2 min read
• Press Releases

  Traws Pharma Provides Regulatory Update on Influenza Program

  June 14, 2026

   · 

  5 min read
• Press Releases

  PreludeDx™ Achieves New Milestones for DCIS Patients and DCISionRT® Testing

  June 14, 2026

   · 

  4 min read
• Press Releases

  XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange

  June 14, 2026

   · 

  4 min read
• Press Releases

  FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Cell Renal Cell Carcinoma (ccRCC)

  June 14, 2026

   · 

  19 min read
• Press Releases

  Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes

  June 14, 2026

   · 

  9 min read
• Press Releases

  Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 12, 2026

  June 14, 2026

   · 

  3 min read
• Press Releases

  Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds

  June 14, 2026

   · 

  5 min read